top of page
FDA announces final guidance recommending Acceptable Intake (AI) Limits for NDSRI
FDA has recently published final Guidance for Industry, entitled “Recommended Acceptable Intake Limits for Nitrosamine Drug...
Content Desk
2 min read
FDA Publishes Final Rule on Requirement for Patient Medication
FDA is proposing to amend its drug product labeling rules for Medication Guide and other information templates provided to...
Content Desk
2 min read
FDA New Labeling & Safety Warnings for Opioids
In response to complaints that patients' sensitivity to pain or level of discomfort increased when using immediate-release (IR) and...
Content Desk
2 min read
bottom of page